Dr. Benjamin Ungar

Claim this profile

Icahn School of Medicine at Mount Sinai

Studies Seborrhea
Studies Vasculopathic Skin Disease
4 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
Icahn School Of Medicine At Mount Sinai

More about Benjamin Ungar

Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Benjamin Ungar has experience with
  • Duobrii
  • PF-07038124
  • Deucravacitinib
  • Ruxolitinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Ungar specialize in?
Benjamin Ungar focuses on Seborrhea and Vasculopathic Skin Disease. In particular, much of their work with Seborrhea has involved treating patients, or patients who are undergoing treatment.
Is Benjamin Ungar currently recruiting for clinical trials?
No, Benjamin Ungar is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Benjamin Ungar has studied deeply?
Yes, Benjamin Ungar has studied treatments such as Duobrii, PF-07038124, Deucravacitinib.
What is the best way to schedule an appointment with Benjamin Ungar?
Apply for one of the trials that Benjamin Ungar is conducting.
What is the office address of Benjamin Ungar?
The office of Benjamin Ungar is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.